Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia.
Manabe
A
A
Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan. manabe@ims.u-tokyo.ac.jp
Takahashi
K
K
Shibata
R
R
Takeuchi
M
M
Morita
M
M
Hosoya
R
R
D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction
D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D003520:Cyclophosphamide; D011239:Prednisolone; D008727:Methotrexate